Jane Yeo

Statistics

Publications

Citations

1.6K

H-Index

Active since

1983

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

GlaxoSmithKline (United Kingdom)

Wellcome Trust

University of Cape Town

Jane Yeo is an author at Research Triangle Park Foundation specializing in infectious disease pharmacotherapy, antiviral therapy, and pharmacotherapy.

Publications per year

1983–2014

Publications

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

Antonella Castagna, Franco Maggiolo, Giovanni Penco et al. · The Journal of Infectious Diseases · 2014 · 329 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study

Joseph J. Eron, Bonaventura Clotet, J. Durant et al. · The Journal of Infectious Diseases · 2012 · 312 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

SOLO

Joseph Gathe, Prudence Ive, Robin Wood et al. · AIDS · 2004 · 196 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult Subjects

Cindy Brothers, Jaime E. Hernández, Amy Cutrell et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2009 · 182 citations

Medicine, Cardiology, Pharmacology +15

Successful treatment of herpes labialis with topical acyclovir.

A. P. Fiddian, Jane Yeo, R Stubbings et al. · BMJ · 1983 · 124 citations · Full text

Medicine, Dermatology, Pharmacotherapy +7

1–5 of 14